BRIEF-Elan says proposal by Royalty Pharma remains an indication of interest

LONDON, March 6 Wed Mar 6, 2013 9:37am EST

LONDON, March 6 (Reuters) - Elan Corporation PLC : * Proposal" by royalty pharma remains an indication of interest, is highly

conditional * The "proposal" by royalty pharma remains an indication of interest * Any credible proposal" which may be made by royalty pharma or any other party

will be considered * Source Text :

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.